Ali A. Hanbashi

Jizan, 82912, Saudi Arabia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Retraction notice to "Thermodynamic and kinetic insights into azo dyes photocatalytic degradation on biogenically synthesized ZnO nanoparticles and their antibacterial potential" [Heliyon 10 (2024) e40679].

Retraction notice to "Thermodynamic and kinetic insights into azo dyes photocatalytic degradation on biogenically synthesized ZnO nanoparticles and their antibacterial potential" [Heliyon 10 (2024) e40679].

Journal: Heliyon

Published: August 12, 2026

TPC2 regulates proteomic remodeling, bioenergetic phenotypes, and mitochondrial stress adaptation in melanoma.

TPC2 regulates proteomic remodeling, bioenergetic phenotypes, and mitochondrial stress adaptation in melanoma.

Journal: Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society

Published: February 04, 2026

Exploring apoptotic pathways: implications for cancer, inflammation, and neurodegeneration.

Exploring apoptotic pathways: implications for cancer, inflammation, and neurodegeneration.

Journal: Molecular biology reports

Published: January 17, 2026

Myeloid immune reprogramming in bone metastatic cancer: Mechanistic crosstalk, therapeutic targets and unresolved clinical challenges.

Myeloid immune reprogramming in bone metastatic cancer: Mechanistic crosstalk, therapeutic targets and unresolved clinical challenges.

Journal: Critical reviews in oncology/hematology

Published: December 05, 2025

Identification and validation of key covalent inhibitors targeting lung cancer proteins through integrated In Silico analysis.

Identification and validation of key covalent inhibitors targeting lung cancer proteins through integrated In Silico analysis.

Journal: Biochemical and biophysical research communications

Published: August 22, 2025

Epigenetic alterations in prostate cancer: the role of chromatin remodeling.

Epigenetic alterations in prostate cancer: the role of chromatin remodeling.

Journal: Epigenomics

Published: July 22, 2025

Epigenetic therapy meets targeted protein degradation: HDAC-PROTACs in cancer treatment.

Epigenetic therapy meets targeted protein degradation: HDAC-PROTACs in cancer treatment.

Journal: Future medicinal chemistry

Published: July 16, 2025

Correction: Non-coding RNAs as key regulators in hepatitis B virus-related hepatocellular carcinoma.

Correction: Non-coding RNAs as key regulators in hepatitis B virus-related hepatocellular carcinoma.

Journal: Frontiers in immunology

Published: June 25, 2025

CRISPR-Edited Cell Lines: A New Era in Functional Oncology Research.

CRISPR-Edited Cell Lines: A New Era in Functional Oncology Research.

Journal: Current pharmaceutical design

Published: May 07, 2025

PANoptosis in Cytokine Release Syndrome: Bridging the Gap between Inflammation and Cell Death.

PANoptosis in Cytokine Release Syndrome: Bridging the Gap between Inflammation and Cell Death.

Journal: Current pharmaceutical design

Published: April 05, 2025

Non-coding RNAs as key regulators in hepatitis B virus-related hepatocellular carcinoma.

Non-coding RNAs as key regulators in hepatitis B virus-related hepatocellular carcinoma.

Journal: Frontiers in immunology

Published: March 29, 2025

Cancer Stem Cell-targeted Antibody-drug Conjugates for Cancer Immunotherapy.

Cancer Stem Cell-targeted Antibody-drug Conjugates for Cancer Immunotherapy.

Journal: Current medicinal chemistry

Published: February 15, 2025

Showing 1-12 of 23

Last Updated: 09/26/2026